Long COVID app needs more Saskatchewan input | Globalnews.ca
Global News
“… app created by the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan. Story continues below advertisement.”
TAGS: COVID-19, pandemic, long-COVID, VIDO-InterVac, University of Saskatchewan
New treatment could reduce tissue damage in Duchenne muscular dystrophy patients by as much as 50 per cent
Canadian Glycomics
“A carbohydrate-derived drug shows promise as a treatment to slow progression of the most common form of muscular dystrophy.”
TAGS: Duchenne muscular dystrophy, genetics, disease progression, treatment, GlycoNet
Truth may literally be in the eye of the beholder – How a novel biomarker could support earlier, non-invasive diagnosis and treatment for ALS
ALS Canada
“With funding from the ALS Society of Canada and Brain Canada, an interdisciplinary team from Unity Health Toronto, led by Dr. Yeni Yucel and Dr. Neeru Gupta, is using widely available imaging technology to find out something completely novel: what eyes can tell us about ALS.”
TAGS: ALS, imaging, medical technology, biomarker, ALS Society of Canada
Let’s change the conversation about diabetes: Ending the stigma underpins efforts to more …
The Globe and Mail
“Diabetes Canada is making it a priority to “change the conversation about diabetes” – focusing on challenging the harmful myths and misconceptions …”
TAGS: diabetes, TD1, Diabetes Canada
Making health care work for people with opioid use disorder – UBC Faculty of Medicine
UBC Faculty of Medicine – The University of British Columbia
“Housed within Providence Health Care, the B.C. Centre on Substance Use is a UBC Faculty of Medicine centre focused on substance use and addiction …”
TAGS: opioid use disorder, healthcare, safe injection sites, Providence Health Care, Vancouver Coastal Health Research Institute
Beyond basic research: Coming to grips with a rare disease experience | McGill University …
McGill University Health Centre
“… of the McGill University Health Centre (RI-MUHC), Grant brings an insider’s perspective to a research laboratory focused on the immune system.”
TAGS: rare disease, autoimmune, innovative research, RI-MUHC